# Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus

> **NCT04441658** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Type 2 Diabetes
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cells
- **BIOLOGICAL:** saline

## Key facts

- **NCT ID:** NCT04441658
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-10
- **Primary completion:** 2022-07
- **Final completion:** 2022-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441658, "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04441658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*